<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.104084</article-id><article-id pub-id-type="publisher-id">ACM-35103</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200400000_57892330.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  胃癌危险因素的病例对照研究
  Case-Control Study of Risk Factors for Gastric Cancer
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>宋</surname><given-names>晓旭</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>莎莎</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郭</surname><given-names>婧</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>齐</surname><given-names>卫卫</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>丁</surname><given-names>爱萍</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>晖</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>钊</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>功竣</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邱</surname><given-names>文生</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院肿瘤内科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>04</month><year>2020</year></pub-date><volume>10</volume><issue>04</issue><fpage>537</fpage><lpage>545</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   目的：探究原发性胃癌的相关危险因素，制定对应的预防治疗措施。方法：根据相关筛选标准，在2014年1月至2018年12月期间青岛大学附属医院收治的患者中，随机抽取500例胃癌患者和500例非胃癌患者分别作为胃癌组和对照组。提取两组患者的BMI、吸烟、饮酒、慢性胃炎病史、糖尿病病史、高血压病史、冠心病病史、消化系统肿瘤家族史等情况进行统计。使用相对数指标对两组的一般资料进行描述性统计；定类资料组间进行卡方检验；进行Logistic回归分析，运用比值比分析多种因素之间的相互作用。结果：两组受研究对象在糖尿病病史、高血压病史、冠心病病史等方面数据无统计学差异(P &gt; 0.05)，在BMI、吸烟、饮酒、慢性胃炎病史、消化系统肿瘤家族史方面数据差异有统计学意义(P &lt; 0.05)。将有统计学意义的数据纳入回归统计分析，结果显示为吸烟(P = 0.024, OR = 1.473)，慢性胃炎病史(P = 0.033, OR = 2.546)，消化系统肿瘤家族史(P = 0.004, OR = 4.031)。结论：吸烟、慢性胃炎病史、消化道系统肿瘤家族史是引起原发性胃癌的独立危险因素。 Objective: To explore the relevant risk factors of primary gastric cancer, and to formulate corre-sponding preventive and therapeutic measures. Methods: According to the relevant screening cri-teria, from January 2014 to December 2018, 500 gastric cancer patients randomly selected as the gastric cancer group and 500 non-gastric cancer patients were randomly selected as the control group from the patients who were treated in our hospital. BMI, smoking, drinking, history of chronic gastritis, history of diabetes, history of hypertension, history of coronary heart disease and family history of digestive system tumors were collected for statistical analysis. The relative numbers were used for descriptive statistics on the general data of the two groups. Chi-square tests were performed between the measurement data groups. Logistic regression analysis was performed, and the interaction between multiple factors was analyzed using odds ratios. Results: There were no statistically significant differences in the data of history of diabetes, hypertension and coronary heart disease in the two groups of subjects (P &gt; 0.05). There were statistically significant differences in BMI, smoking, drinking, history of chronic gastritis and family history of digestive system (P &lt; 0.05). The statistically significant data were included in the regression statistical analysis, and the results showed smoking (P = 0.024, OR = 1.473), history of chronic gastritis (P = 0.033, OR = 2.546), family history of digestive system tumors (P = 0.004, OR = 4.031). Conclusion: Smoking, history of chronic gastritis, and family history of gastrointestinal tumors are independent risk factors for primary gastric cancer. 
 
</p></abstract><kwd-group><kwd>胃癌，危险因素，病例对照研究，预防, Gastric Cancer</kwd><kwd> Risk Factors</kwd><kwd> Case-Control Study</kwd><kwd> Prevention</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>胃癌危险因素的病例对照研究<sup> </sup></title><p>宋晓旭<sup>*</sup>，王莎莎<sup>*</sup>，郭婧，齐卫卫，丁爱萍，李晖，刘钊，王功竣，邱文生<sup>#</sup></p><p>青岛大学附属医院肿瘤内科，山东 青岛</p><disp-formula id="hanspub.35103-formula21"><graphic xlink:href="//html.hanspub.org/file/11-1571256x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2020年3月26日；录用日期：2020年4月10日；发布日期：2020年4月17日</p><disp-formula id="hanspub.35103-formula22"><graphic xlink:href="//html.hanspub.org/file/11-1571256x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探究原发性胃癌的相关危险因素，制定对应的预防治疗措施。方法：根据相关筛选标准，在2014年1月至2018年12月期间青岛大学附属医院收治的患者中，随机抽取500例胃癌患者和500例非胃癌患者分别作为胃癌组和对照组。提取两组患者的BMI、吸烟、饮酒、慢性胃炎病史、糖尿病病史、高血压病史、冠心病病史、消化系统肿瘤家族史等情况进行统计。使用相对数指标对两组的一般资料进行描述性统计；定类资料组间进行卡方检验；进行Logistic回归分析，运用比值比分析多种因素之间的相互作用。结果：两组受研究对象在糖尿病病史、高血压病史、冠心病病史等方面数据无统计学差异(P &gt; 0.05)，在BMI、吸烟、饮酒、慢性胃炎病史、消化系统肿瘤家族史方面数据差异有统计学意义(P &lt; 0.05)。将有统计学意义的数据纳入回归统计分析，结果显示为吸烟(P = 0.024, OR = 1.473)，慢性胃炎病史(P = 0.033, OR = 2.546)，消化系统肿瘤家族史(P = 0.004, OR = 4.031)。结论：吸烟、慢性胃炎病史、消化道系统肿瘤家族史是引起原发性胃癌的独立危险因素。</p><p>关键词 :胃癌，危险因素，病例对照研究，预防</p><disp-formula id="hanspub.35103-formula23"><graphic xlink:href="//html.hanspub.org/file/11-1571256x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/11-1571256x8_hanspub.png" /> <img src="//html.hanspub.org/file/11-1571256x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>胃癌是造成全球癌症负担的重要因素之一 [<xref ref-type="bibr" rid="hanspub.35103-ref1">1</xref>]。不到一个世纪之前，胃癌是世界上最常见的癌症 [<xref ref-type="bibr" rid="hanspub.35103-ref2">2</xref>]。近年来尽管全球胃癌发病率有所下降，但胃癌仍是最常见的消化系统肿瘤。我国是胃癌高发区，发病率及死亡率均超出世界平均水平 [<xref ref-type="bibr" rid="hanspub.35103-ref3">3</xref>]。胃癌患者早期症状不明显，且病情发展迅速，一经诊断多为晚期，晚期胃癌预后较差，5年生存率低于30% [<xref ref-type="bibr" rid="hanspub.35103-ref4">4</xref>]。胃癌的发生是有多种因素共同参与的复杂过程，与胃癌发生发展相关的危险因素较多。因此，寻找胃癌相关危险因素，针对各项危险因素进行早期干预，对胃癌发病高危人群进行精准防控，以达到降低胃癌发病率及死亡率的最终目的。本文旨在寻找胃癌危险因素，探究个相关因素与胃癌发生的相关程度，为胃癌防止策略的制定提供一定的理论基础。</p></sec><sec id="s4"><title>2. 资料与方法</title><sec id="s4_1"><title>2.1. 研究资料</title><p>本研究采用回顾性研究方法，已通过我院医学伦理委员会审批。根据相关筛选标准，在2014年1月至2018年12月期间青岛大学附属医院收治的患者中，随机抽取500例胃癌患者和500例非胃癌患者分别作为胃癌组和对照组。胃癌组纳入标准：① 在我院经过胃镜病理或手术病理确诊的胃癌新发病例；②户口所在地为青岛；排除标准：① 继发性胃癌患者；② 户口所在地为非青岛；③ 伴有其他肿瘤病史；④ 伴有严重的心、脑、肺等主要器官疾病患者。对照组纳入标准：① 我院同期收治的非胃癌患者；②户口所在地为青岛；排除标准：① 伴有其他肿瘤病史；② 户口所在地为非青岛；③ 伴有严重的心、脑、肺等主要器官疾病患者。通过查阅病历，对胃癌组和对照组中每位患者的BMI、吸烟史、饮酒史、慢性胃炎病史、糖尿病病史、高血压病史、冠心病病史、消化系统肿瘤家族史等情况进行收集、整理。</p></sec><sec id="s4_2"><title>2.2. 统计学方法</title><p>本次研究统计的数据表用Epidate3.1建立数据库，采用SPSS18..0和SAS9.2软件对数据进行统计分析，定类资料采用秩和检验和χ<sup>2</sup>检验，一般采用单因素卡方检验，初步筛选出具有统计学意义的因素(P &lt; 0.05)；对具有统计学意义的因素进行Logistic多因素分析，从而得出各因素之间与原发性胃癌之间的关联强度，明确原发性胃癌的独立危险因素。</p></sec></sec><sec id="s5"><title>3. 结果</title><sec id="s5_1"><title>3.1. 胃癌发病的单因素分析</title><p>本次研究对象共1000例，胃癌组与对照组各500例，对两组对象的年龄、性别等基本信息及BMI、吸烟史、饮酒史、肿瘤家族史、慢性胃炎病史等因素进行了单因素分析，结果如下：</p><sec id="s5_1_1"><title>3.1.1. 年龄与胃癌发病的相关性分析</title><p>对两组患者的年龄进行统计分析，各年龄段结果不同，整体结果显示两组在年龄方面数据差异无统计学意义(P &gt; 0.05) (表1)。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution and comparison of age between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >年龄(岁)</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >&lt;40</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >114</td><td align="center" valign="middle"  rowspan="6"  >0.063</td><td align="center" valign="middle"  rowspan="6"  >0.837</td></tr><tr><td align="center" valign="middle" >40~49</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >152</td></tr><tr><td align="center" valign="middle" >50~59</td><td align="center" valign="middle" >106</td><td align="center" valign="middle" >109</td><td align="center" valign="middle" >215</td></tr><tr><td align="center" valign="middle" >60~69</td><td align="center" valign="middle" >177</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >285</td></tr><tr><td align="center" valign="middle" >70~79</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >177</td></tr><tr><td align="center" valign="middle" >≥80</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >57</td></tr></tbody></table></table-wrap><p>表1. 两组患者年龄分布情况及比较</p></sec><sec id="s5_1_2"><title>3.1.2. 性别与胃癌发病的相关性分析</title><p>对两组对象的性别进行统计，结果发现两组患者在性别方面数据差异无统计学意义(P &gt; 0.05) (表2)。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution and comparison of age between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >性别</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >男</td><td align="center" valign="middle" >329</td><td align="center" valign="middle" >234</td><td align="center" valign="middle" >563</td><td align="center" valign="middle"  rowspan="2"  >2.058</td><td align="center" valign="middle"  rowspan="2"  >0.051</td></tr><tr><td align="center" valign="middle" >女</td><td align="center" valign="middle" >171</td><td align="center" valign="middle" >266</td><td align="center" valign="middle" >437</td></tr></tbody></table></table-wrap><p>表2. 胃癌组与对照组性别分布对照表</p></sec><sec id="s5_1_3"><title>3.1.3. BMI与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的BMI进行统计分析，发现两组对象在BMI方面数据差异有统计学意义(P &lt; 0.05) (表3)。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of BMI between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >BMI (Kg/m<sup>2</sup>)</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >&lt;18</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >43</td><td align="center" valign="middle"  rowspan="3"  >12.761</td><td align="center" valign="middle"  rowspan="3"  >0.024</td></tr><tr><td align="center" valign="middle" >18~24</td><td align="center" valign="middle" >202</td><td align="center" valign="middle" >271</td><td align="center" valign="middle" >473</td></tr><tr><td align="center" valign="middle" >&gt;24</td><td align="center" valign="middle" >277</td><td align="center" valign="middle" >207</td><td align="center" valign="middle" >484</td></tr></tbody></table></table-wrap><p>表3. 两组患者BMI情况比较</p></sec><sec id="s5_1_4"><title>3.1.4. 吸烟与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的吸烟情况进行统计分析，发现两组患者在吸烟方面数据差异具有统计学意义(P &lt; 0.05)，在烟龄方面的差异具有统计学意义(P &lt; 0.05) (表4)。</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Comparison of smoking between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >吸烟</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >是</td><td align="center" valign="middle" >212</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >297</td><td align="center" valign="middle"  rowspan="2"  >12.054</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle" >否</td><td align="center" valign="middle" >288</td><td align="center" valign="middle" >415</td><td align="center" valign="middle" >703</td></tr><tr><td align="center" valign="middle" >烟龄(年)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >19</td><td align="center" valign="middle"  rowspan="3"  >8.456</td><td align="center" valign="middle"  rowspan="3"  >0.015</td></tr><tr><td align="center" valign="middle" >20~40</td><td align="center" valign="middle" >173</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >237</td></tr><tr><td align="center" valign="middle" >&gt;40</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >41</td></tr></tbody></table></table-wrap><p>表4. 两组患者吸烟情况比较</p></sec><sec id="s5_1_5"><title>3.1.5. 饮酒与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的饮酒情况进行统计，发现两组患者在饮酒方面数据差异具有统计学意义(P &lt; 0.05)，在酒龄方面的差异具有统计学意义(P &lt; 0.05) (表5)。</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Comparison of drinking between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >饮酒</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >是</td><td align="center" valign="middle" >176</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >246</td><td align="center" valign="middle"  rowspan="2"  >7.253</td><td align="center" valign="middle"  rowspan="2"  >0.013</td></tr><tr><td align="center" valign="middle" >否</td><td align="center" valign="middle" >324</td><td align="center" valign="middle" >430</td><td align="center" valign="middle" >754</td></tr><tr><td align="center" valign="middle" >酒龄(年)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17</td><td align="center" valign="middle"  rowspan="3"  >10.948</td><td align="center" valign="middle"  rowspan="3"  >0.025</td></tr><tr><td align="center" valign="middle" >20~40</td><td align="center" valign="middle" >146</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >216</td></tr><tr><td align="center" valign="middle" >&gt;40</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >18</td></tr></tbody></table></table-wrap><p>表5. 两组患者饮酒情况比较</p></sec><sec id="s5_1_6"><title>3.1.6. 消化系统肿瘤家族史与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的消化系统肿瘤家族史情况进行统计，发现两组对象在消化系统肿瘤家族史方面数据差异具有统计学意义(P &lt; 0.05) (表6)。</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Comparison of family history of digestive system tumors between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >消化系统肿瘤家族史</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >是</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >79</td><td align="center" valign="middle"  rowspan="2"  >5.743</td><td align="center" valign="middle"  rowspan="2"  >0.011</td></tr><tr><td align="center" valign="middle" >否</td><td align="center" valign="middle" >440</td><td align="center" valign="middle" >481</td><td align="center" valign="middle" >921</td></tr></tbody></table></table-wrap><p>表6. 两组患者消化系统肿瘤家族史情况比较</p></sec><sec id="s5_1_7"><title>3.1.7. 慢性胃炎病史与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的胃炎病史情况进行统计，发现两组对象在慢性胃炎病史方面数据差异具有统计学意义(P &lt; 0.05) (表7)。</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Comparison of history of chronic gastritis between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >胃炎病史</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >是</td><td align="center" valign="middle" >235</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >333</td><td align="center" valign="middle"  rowspan="2"  >5.674</td><td align="center" valign="middle"  rowspan="2"  >0.038</td></tr><tr><td align="center" valign="middle" >否</td><td align="center" valign="middle" >265</td><td align="center" valign="middle" >402</td><td align="center" valign="middle" >667</td></tr></tbody></table></table-wrap><p>表7. 两组患者慢性胃炎病史情况比较</p></sec><sec id="s5_1_8"><title>3.1.8. 糖尿病病史与胃癌发病的相关性分析</title><p>对胃癌组及对照组患者的糖尿病病史情况进行统计，发现两组对象在糖尿病史方面数据差异无统计学意义(P &gt; 0.05) (表8)。</p><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Comparison of history of diabetes between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >糖尿病史</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >有</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >82</td><td align="center" valign="middle"  rowspan="2"  >1.562</td><td align="center" valign="middle"  rowspan="2"  >0.846</td></tr><tr><td align="center" valign="middle" >无</td><td align="center" valign="middle" >552</td><td align="center" valign="middle" >566</td><td align="center" valign="middle" >918</td></tr></tbody></table></table-wrap><p>表8. 两组患者糖尿病病史情况比较</p></sec><sec id="s5_1_9"><title>3.1.9. 高血压病史与胃癌发病的相关性分析</title><p>对两组对象高血压病史情况进行统计，发现两组患者在高血压病史方面数据差异无统计学意义(P &gt; 0.05) (表9)。</p><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Comparison of history of hypertension between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >高血压病史</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >有</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >195</td><td align="center" valign="middle"  rowspan="2"  >2.047</td><td align="center" valign="middle"  rowspan="2"  >0.836</td></tr><tr><td align="center" valign="middle" >无</td><td align="center" valign="middle" >388</td><td align="center" valign="middle" >417</td><td align="center" valign="middle" >805</td></tr></tbody></table></table-wrap><p>表9. 两组患者高血压病史情况比较</p></sec><sec id="s5_1_10"><title>3.1.10. 冠心病史与胃癌发病的相关性分析</title><p>对两组对象冠心病史情况进行统计，发现两组对象在冠心病史方面数据无统计学差异(P &gt; 0.05) (表10)。</p><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> Comparison of history of coronary heart disease between two group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >冠心病史</th><th align="center" valign="middle" >胃癌组(n)</th><th align="center" valign="middle" >对照组(n)</th><th align="center" valign="middle" >合计</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >有</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >62</td><td align="center" valign="middle"  rowspan="2"  >1.956</td><td align="center" valign="middle"  rowspan="2"  >0.573</td></tr><tr><td align="center" valign="middle" >无</td><td align="center" valign="middle" >458</td><td align="center" valign="middle" >480</td><td align="center" valign="middle" >938</td></tr></tbody></table></table-wrap><p>表10. 两组患者冠心病史情况比较</p></sec></sec><sec id="s5_2"><title>3.2. 胃癌发病的多因素分析</title><p>根据单因素分析结果，将有统计学意义的因素(P &lt; 0.05) BMI、吸烟、饮酒、消化系统肿瘤家族史、慢性胃炎病史纳入Logistic多因素分析，根据OR值可知，吸烟、慢性胃炎病史、消化道系统肿瘤家族史等情况是引起原发性胃癌的独立危险因素(OR &gt; 1) (表11)。</p><table-wrap id="table11" ><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> Multivariate Logistic analysis result</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >因素</th><th align="center" valign="middle" >β</th><th align="center" valign="middle" >SE</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P值</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >95% CI</th></tr></thead><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >0.451</td><td align="center" valign="middle" >0.318</td><td align="center" valign="middle" >4.143</td><td align="center" valign="middle" >0.045</td><td align="center" valign="middle" >0.574</td><td align="center" valign="middle" >2.261~3.195</td></tr><tr><td align="center" valign="middle" >吸烟</td><td align="center" valign="middle" >0.358</td><td align="center" valign="middle" >0.331</td><td align="center" valign="middle" >5.342</td><td align="center" valign="middle" >0.024</td><td align="center" valign="middle" >1.473</td><td align="center" valign="middle" >1.034~4.043</td></tr><tr><td align="center" valign="middle" >饮酒</td><td align="center" valign="middle" >0.656</td><td align="center" valign="middle" >0.255</td><td align="center" valign="middle" >6.653</td><td align="center" valign="middle" >0.024</td><td align="center" valign="middle" >0.636</td><td align="center" valign="middle" >0.358~0.895</td></tr><tr><td align="center" valign="middle" >消化系统肿瘤家族史</td><td align="center" valign="middle" >1.475</td><td align="center" valign="middle" >0.381</td><td align="center" valign="middle" >5.941</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >4.031</td><td align="center" valign="middle" >0.135~0.388</td></tr><tr><td align="center" valign="middle" >慢性胃炎病史</td><td align="center" valign="middle" >1.032</td><td align="center" valign="middle" >0.753</td><td align="center" valign="middle" >3.194</td><td align="center" valign="middle" >0.033</td><td align="center" valign="middle" >2.546</td><td align="center" valign="middle" >0.153~0.586</td></tr></tbody></table></table-wrap><p>表11. 多因素Logistic分析结果</p></sec></sec><sec id="s6"><title>4. 讨论</title><sec id="s6_1"><title>4.1. BMI与胃癌发生的相关性</title><p>身体质量指数(BMI, Body Mass Index)是国际上常用的衡量人体肥胖程度和健康程度的标准。人体肥胖程度不仅与体重有关，还与身高有关 [<xref ref-type="bibr" rid="hanspub.35103-ref5">5</xref>]。因此，BMI通过人体体重和身高两个数值获得相对客观的参数，并用这个参数所处范围衡量身体质量。在本次研究中将BMI进行了分段分析，分析结果显示，在身体质量指数方面，两组数据差异具有统计学意义(P &lt; 0.05)。胃癌组的肥胖人数明显多于对照组，这与很多文献研究一致。Yang P.等 [<xref ref-type="bibr" rid="hanspub.35103-ref6">6</xref>] 进行的一项关于肥胖与胃癌关系的荟萃分析结果显示，肥胖与胃癌的发生呈正相关，且BMI越大，患胃癌的风险越高。一项来自美国的前瞻性队列研究结果显示，BMI ≥ 35 Kg/m<sup>2</sup>的人群中发生胃贲门癌的风险明显高于BMI正常的人群，并且进一步发现了腹围值与贲门癌发病存在密切相关 [<xref ref-type="bibr" rid="hanspub.35103-ref7">7</xref>]。肥胖导致胃癌的确切机制目前尚不明确，可能与胰岛素抵抗、胃食管反流的形成、高血糖的形成、免疫应答的异常以及脂肪因子(瘦素、脂联素)代谢异常等有关 [<xref ref-type="bibr" rid="hanspub.35103-ref8">8</xref>]。要想保持正常的BMI，除了合理的饮食结构，还要能够做到长期的锻炼。</p></sec><sec id="s6_2"><title>4.2. 吸烟与胃癌发生的相关性</title><p>有文献研究指出，吸烟已经被确定为胃癌发生的危险因素之一 [<xref ref-type="bibr" rid="hanspub.35103-ref9">9</xref>]。这与本研究发现吸烟作为胃癌发生的独立危险因素的结果一致。Abraham等 [<xref ref-type="bibr" rid="hanspub.35103-ref10">10</xref>] 研究发现，吸烟人群胃癌的发病率明显高于不吸烟人群，并且这种差异与吸烟强度(日吸烟量)以及吸烟史持续时间相关，同时还发现在吸烟者人群中，患贲门癌的比率高于非贲门癌。本研究中同样根据烟龄进行了分段分析，结果提示两组差异具有统计学意义(P &lt; 0.05)。此外，欧洲的一项研究结果同样提示胃癌发病率与吸烟史持续时间的相关性 [<xref ref-type="bibr" rid="hanspub.35103-ref11">11</xref>]。吸烟对胃癌发病影响的具体机制目前尚不明确。但是，烟雾中的尼古丁以及N-亚硝基化合物都是已确定的致癌物质 [<xref ref-type="bibr" rid="hanspub.35103-ref12">12</xref>]。</p></sec><sec id="s6_3"><title>4.3. 饮酒与胃癌发生的相关性</title><p>本研究发现饮酒不是胃癌的独立危险因素，但与胃癌发生存在一定的相关性。韩国的一项病例对照研究发现，高酒精摄入量(女性 ≥ 20 g/天或男性 ≥ 40 g/天)显著增加了胃癌发病的风险，胃癌发病风险与日饮酒量(≥20 g)呈正相关 [<xref ref-type="bibr" rid="hanspub.35103-ref13">13</xref>]。日本的一项研究发现，酒精摄入量与贲门癌的发病风险呈正相关 [<xref ref-type="bibr" rid="hanspub.35103-ref14">14</xref>]。胃癌的发生还与酒精的种类有关。研究发现，相对于不饮酒的人，啤酒和白酒消费量高的人发病风险升高，葡萄酒与胃癌的发生无明显关联 [<xref ref-type="bibr" rid="hanspub.35103-ref15">15</xref>]。关于酒精引起胃癌发生的机制，研究发现酒精在体内的代谢产物乙醛可以引起胃黏膜细胞的损伤，使得亚硝基化合物等致癌物质的吸收增加，从而导致胃癌的发生 [<xref ref-type="bibr" rid="hanspub.35103-ref16">16</xref>]。国际癌症研究机构现已将酒精饮料和与之有关的乙醛归入人类的第一类致癌物质 [<xref ref-type="bibr" rid="hanspub.35103-ref17">17</xref>]。所以在平时的生活中，那些观点认为饮酒适量对身体有益均是错误的。</p></sec><sec id="s6_4"><title>4.4. 肿瘤家族史与胃癌发生的相关性</title><p>本研究中消化系统肿瘤家族史与胃癌发生之间具有较强的相关性，可以作为胃癌发病的独立危险因素。很多国内、外研究也显示胃癌发生存在一定程度的家族聚集性。研究发现，有胃癌家族史(一级亲属)人群患胃癌的风险比没有胃癌家族史人群增加1.5~3.5倍 [<xref ref-type="bibr" rid="hanspub.35103-ref18">18</xref>]。也有研究发现，有胃癌的父母能够大大增加子女患癌症的风险 [<xref ref-type="bibr" rid="hanspub.35103-ref19">19</xref>]。胃癌的遗传易感性有强、弱之分，强遗传易感性胃癌患者多见于遗传综合征家族，例如遗传性弥漫性胃癌(Hereditary diffuse gastric cancer, HDGC)，HDGC是由钙黏蛋白相关基因突变引起的，基因突变携带者发生胃癌的概率为80%。但遗传综合征导致的家族聚集性胃癌仅占1%~3% [<xref ref-type="bibr" rid="hanspub.35103-ref20">20</xref>]。90%以上的散发性胃癌属于弱遗传易感性，可能与单核苷酸的基因多态性(single nucleotide genetic polymorphisms, SNP)相关 [<xref ref-type="bibr" rid="hanspub.35103-ref21">21</xref>]。胃癌家族史人群具有更高胃癌发生风险的原因可能与家庭成员有共同的生活方式、饮食习惯等原因有关。因此，有胃癌家族史的人群，应具备风险意识，对自身的生活方式及饮食习惯进行规范，尽最大程度规避其他胃癌危险因素。此外，应对城市基层医疗卫生增加投入，对有肿瘤家族史的人群进行登记，做好宣教工作，最大程度降低患癌风险。</p></sec><sec id="s6_5"><title>4.5. 消化道相关疾病史与胃癌发生的相关性</title><p>相关学者认为胃癌的发生是经历慢性胃炎、胃粘膜肠化、异性增生及癌变等步骤演变的复杂过程。在这个过程中，胃粘膜细胞增殖和凋亡之间失去正常的动态平衡，胃癌相关原癌基因激活，抑癌基因受到抑制，导致上皮细胞过度增殖，凋亡信号无法启动，从而导致胃癌发生。慢性萎缩性胃炎(Chronic atrophic gastritis, CAG)患者胃部外分泌腺体功能受损，胃酸分泌减少，胃内PH 值升高，有利于细菌定植，促使内源性亚硝酸化合物等致癌物质合成。因此，CAG被认为是重要的胃癌癌前疾病 [<xref ref-type="bibr" rid="hanspub.35103-ref22">22</xref>]。本次研究显示患有慢性胃炎病史会显著增加胃癌发生风险，和多数流行病学研究结果一致。</p><p>研究发现，幽门螺旋杆菌(H. pylori)是导致慢性胃炎的主要致病菌。根据流行病学调查，全球75%的胃癌发病与H. pylori感染有关 [<xref ref-type="bibr" rid="hanspub.35103-ref23">23</xref>]，世界卫生组织已于1994年将革兰阴性杆菌H. pylori定性为胃癌的I类致癌物 [<xref ref-type="bibr" rid="hanspub.35103-ref24">24</xref>]。但H. pylori感染引起胃癌的确切机制尚不完全清楚，目前认为可能的两种机制为：① H. pylori对胃黏膜上皮细胞的直接表观遗传学作用和H. pylori对胃黏膜的间接炎症反应 [<xref ref-type="bibr" rid="hanspub.35103-ref24">24</xref>]；② 具有某些毒力因子的H. pylori菌株更有可能增加胃癌发病的风险。H. pylori菌株的毒力因子有多种，例如细胞毒素相关基因A (cytotoxin-associated gene A, CagA)和空泡毒素相关基因A (vacuolar protein toxin-related human A, VacA)。尽管H. pylori感染与胃癌发生密切相关，但目前是否需要在人群中大规模进行H. pylori根除尚存争议，因为考虑到大量使用抗生素对肠道菌群的影响以及细菌耐药性的产生。但是，对于已发生胃黏膜萎缩、肠化及轻、中度不典型增生的H. pylori感染者，大部分研究主张进行H. pylori根除 [<xref ref-type="bibr" rid="hanspub.35103-ref25">25</xref>]。</p></sec><sec id="s6_6"><title>4.6. 慢性病史与胃癌发生的相关性</title><p>本次研究中加入慢性病因素，是因为考虑到中老年人胃癌发病率高，且多伴有高血压、糖尿病、冠心病等慢性病。这些慢性病长期影响中老年人的生活，一旦控制不佳，可能会导致更严重的后果。但是慢性病史与胃癌发生之间是否存在相关性还有待进一步讨论。根据相关情况推测，相较于正常人，长期患有糖尿病、高血压、冠心病等疾病的患者免疫力低下，更容易引起胃癌的发生。但在本次研究中尚未发现高血压、糖尿病、冠心病等疾病病史与胃癌发生之间存在相关性。</p></sec><sec id="s6_7"><title>4.7. 其他因素与胃癌发生的相关性</title><p>除了本次研究所涉及到的因素，还有其他因素会引起胃癌的发生。世界癌症研究基金(World Cancer Research Fund, WCRF)与美国癌症研究所(American Institute for Cancer Research, AICR)得出的结论是：食盐和腌制食物可能与胃癌的发生有关 [<xref ref-type="bibr" rid="hanspub.35103-ref26">26</xref>]。胃癌患病风险在一定范围内随食盐摄入量的增加而增加。另外，熏制肉类也会增加胃癌发生风险。西班牙的一项回顾性研究分析显示，通过熏制肉类摄入亚硝酸盐与胃癌发生存在正相关 [<xref ref-type="bibr" rid="hanspub.35103-ref27">27</xref>]。</p><p>精神因素也可以作为增加胃癌患病风险的因素之一。在抑郁、焦虑等精神压抑状态下，机体产生T细胞、NK细胞等免疫细胞的数量下降，造成机体免疫力下降，免疫系统分辨、清除肿瘤细胞的能力下降，从而促进胃癌的发生。Lee等 [<xref ref-type="bibr" rid="hanspub.35103-ref28">28</xref>] 研究发现精神压抑可以作为消化系统肿瘤发病的独立危险因素。现代生活使得人们面临的生活压力增加，要学会调节不良情绪，保持乐观心态，降低胃癌等严重疾病的发生风险。</p></sec></sec><sec id="s7"><title>5. 研究的局限与不足</title><p>本次研究通过对某个医院的住院患者进行统计分析，研究对象来自于所选定的特定区域，且样本量较小，由于受环境因素及病例数的影响不可避免会产生偏倚，因此在样本量选择方面还有待进一步扩大区域与人数。此外，胃癌发病是一个多因素共同作用的复杂过程，本研究受病历系统限制，纳入的研究因素有限，对于其他可能导致胃癌发病的危险因素，将来需要更多的研究来验证。</p></sec><sec id="s8"><title>6. 结论</title><p>胃癌是常见的恶性肿瘤之一。胃癌在我国常见恶性肿瘤中排第3位，在癌症相关死因中排第2位。胃癌的发生是内外因素共同作用的结果，针对本文研究得出的相关结果，应针对相关危险因素制定相应的预防策略。通过戒烟限酒、控制体重、保持愉悦心情、减少食用腌制熏制食物、防治H. pylori感染等途径，并定期进行胃镜检查等筛查手段，降低胃癌的发病率及死亡率。</p></sec><sec id="s9"><title>基金项目</title><p>1) 北京希思科临床肿瘤学研究基金(编号Y-HR2018-185)；</p><p>2) 国家自然科学基金(编号81602068)；</p><p>3) 吴阶平医学基金(编号320.6750.19088-29)；</p><p>4) 北京希思科临床肿瘤学研究基金(编号Y-BMS2019-038)。</p></sec><sec id="s10"><title>文章引用</title><p>宋晓旭,王莎莎,郭 婧,齐卫卫,丁爱萍,李 晖,刘 钊,王功竣,邱文生. 胃癌危险因素的病例对照研究Case-Control Study of Risk Factors for Gastric Cancer[J]. 临床医学进展, 2020, 10(04): 537-545. https://doi.org/10.12677/ACM.2020.104084</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.35103-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Van Cutsem, E., Sagaert, X., Topal, B., et al. (2016) Gastric Cancer. The Lancet, 388, 2654-2664. 
&lt;br&gt;https://doi.org/10.1016/S0140-6736(16)30354-3</mixed-citation></ref><ref id="hanspub.35103-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ottavia, C., Serena, S., Chiara, M., et al. (2018) Epidemi-ology of Gastric Cancer and Risk Factors. Acta BioMedica, 89, 82-87.</mixed-citation></ref><ref id="hanspub.35103-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ferlay, J., Soerjomataram, I., Dikshit, R., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. The International Journal of Cancer, 136, E359-E386. 
&lt;br&gt;https://doi.org/10.1002/ijc.29210</mixed-citation></ref><ref id="hanspub.35103-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Saragoni, L. (2015) Upgrading the Definition of Early Gastric Cancer: Better Staging Means More Appropriate Treatment. Cancer Biology &amp; Medicine, 12, 355-361.</mixed-citation></ref><ref id="hanspub.35103-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Nishibeppu, K., Komatsu, S., Ichikawa, D., et al. (2018) Venous Invasion as a Risk Factor for Recurrence after Gastrectomy Followed by Chemotherapy for Stage III Gastric Cancer. BMC Cancer, 18, 108. 
&lt;br&gt;https://doi.org/10.1186/s12885-018-4052-z</mixed-citation></ref><ref id="hanspub.35103-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yang, P., Zhou, Y., Chen, B., et al. (2009) Overweight, Obesity and Gastric Cancer Risk: Results from a Meta-Analysis of Cohort Studies. European Journal of Cancer, 45, 2867-2873. &lt;br&gt;https://doi.org/10.1016/j.ejca.2009.04.019</mixed-citation></ref><ref id="hanspub.35103-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">O’Doherty, M.G., Freedman, N.D., Hollenbeck, A.R., et al. (2012) A Prospective Cohort Study of Obesity and Risk of Esophageal and Gastric Adenocarcinoma in the NIH-AARP Diet and Health Study. Gut, 61, 1261-1268. 
&lt;br&gt;https://doi.org/10.1136/gutjnl-2011-300551</mixed-citation></ref><ref id="hanspub.35103-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Donohoe, C.L., O’Farrell, N.J., Doyle, S.L., et al. (2014) The Role of Obesity in Gastrointestinal Cancer: Evidence and Opinion. Therapeutic Advances in Gastroenterology, 7, 38-50. &lt;br&gt;https://doi.org/10.1177/1756283X13501786</mixed-citation></ref><ref id="hanspub.35103-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Prashanth, R. and Adam, B. (2019) Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Prevention. Gastroenterology Review, 14, 26-38. &lt;br&gt;https://doi.org/10.5114/pg.2018.80001</mixed-citation></ref><ref id="hanspub.35103-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Koizumi, Y., Tsubono, Y., Nakaya, N., et al. (2004) Cigarette Smoking and the Risk of Gastric Cancer: A Pooled Analysis of Two Prospective Studies in Japan. International Journal of Cancer, 112, 1049-1055. 
&lt;br&gt;https://doi.org/10.1002/ijc.20518</mixed-citation></ref><ref id="hanspub.35103-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">González, C.A., Pera, G., Agudo, A., et al. (2003) Smoking and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). International Journal of Cancer, 107, 629-634. 
&lt;br&gt;https://doi.org/10.1002/ijc.11426</mixed-citation></ref><ref id="hanspub.35103-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Huang, R.Y. and Chen, G.G. (2011) Cigarette Smoking, Cyclooxygenase-2 Pathway and Cancer. Biochimica et Biophysica Acta, 1815, 158-169. &lt;br&gt;https://doi.org/10.1016/j.bbcan.2010.11.005</mixed-citation></ref><ref id="hanspub.35103-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mi, H.K., Shin, A.K., Chan, H.P., et al. (2019) Alcohol Con-sumption and Gastric Cancer Risk in Korea: A Case-Control Study. Nutrition Research and Practice, 13, 425-433. &lt;br&gt;https://doi.org/10.4162/nrp.2019.13.5.425</mixed-citation></ref><ref id="hanspub.35103-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y., Eshak, E.S., Kokoro, S., et al. (2019) Alcohol Consumption and Risk of Gastric Cancer: The Japan Collaborative Cohort Study. Journal of Epidemiology.</mixed-citation></ref><ref id="hanspub.35103-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Larsson, S.C., Giovannucci, E. and Wolk, A. (2007) Alcoholic Beverage Consumption and Gastric Cancer Risk: A Prospective Pop-ulation-Based Study in Women. International Journal of Cancer, 120, 373-377. 
&lt;br&gt;https://doi.org/10.1002/ijc.22204</mixed-citation></ref><ref id="hanspub.35103-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Brooks, P.J. and Zakhari, S. (2014) Acetaldehyde and the Genome: Beyond Nuclear DNA Adducts and Carcinogenesis. Environmental and Molecular Mutagenesis, 55, 77-91. &lt;br&gt;https://doi.org/10.1002/em.21824</mixed-citation></ref><ref id="hanspub.35103-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2010) Alcohol Consumption and Ethyl carbamate. International Agency for Research on Cancer, Lyon, France, Geneva.</mixed-citation></ref><ref id="hanspub.35103-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yaghoobi, M., Bijarchi, R. and Narod, S.A. Family History and the Risk of Gastric Cancer. British Journal of Cancer, 102, 237-242. &lt;br&gt;https://doi.org/10.1038/sj.bjc.6605380</mixed-citation></ref><ref id="hanspub.35103-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Seo, H.S., Lee, G.E., Kang, M.G., et al. (2018) Mixed Histology Is a Risk Factor for Lymph Node Metastasis in Early Gastric Cancer. Journal of Surgical Research, 236, 271-277. &lt;br&gt;https://doi.org/10.1016/j.jss.2018.11.055</mixed-citation></ref><ref id="hanspub.35103-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Lynch, H.T., Grady, W., Suriano, G., et al. (2005) Gastric Cancer: New Genetic Developments. Journal of Surgical Oncology, 90, 114-133. &lt;br&gt;https://doi.org/10.1002/jso.20214</mixed-citation></ref><ref id="hanspub.35103-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Kamangar, F., Cheng, C., Abnet, C.C., et al. (2006) Interleukin-1B Poly-morphisms and Gastric Cancer Risk: A Meta-Analysis. Cancer Epidemiology, Biomarkers &amp; Prevention, 15, 1920-1928.  
&lt;br&gt;https://doi.org/10.1158/1055-9965.EPI-06-0267</mixed-citation></ref><ref id="hanspub.35103-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Oshi, M., Kunisaki, C., Miyamoto, H., et al. (2018) Risk Factors for Anastomotic Leakage of Esophagojejunostomy after Laparoscopy-Assisted Total Gastrectomy for Gastric Cancer. Digestive Surgery, 35, 28-34. 
&lt;br&gt;https://doi.org/10.1159/000464357</mixed-citation></ref><ref id="hanspub.35103-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Martel, C., Ferlay, J., Franceschi, S., et al. (2012) Global Burden of Cancers Attributable to Infections in 2008: A Review and Synthetic Analysis. The Lancet Oncology, 13, 607-615. &lt;br&gt;https://doi.org/10.1016/S1470-2045(12)70137-7</mixed-citation></ref><ref id="hanspub.35103-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ishaq, S. and Nunn, L. (2015) Helicobacter Pylori and Gas-tric Cancer: A State-of-the-Art Review. Gastroenterology and Hepatology from Bed to Bench, 8, S6-S14.</mixed-citation></ref><ref id="hanspub.35103-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Fuccio, L., Zagari, R.M., Eusebi, L.H., et al. (2009) Meta-Analysis: Can Helicobacter Pylori Eradication Treatment Reduce the Risk for Gastric Cancer? Annals of Internal Medicine, 151, 121-128. 
&lt;br&gt;https://doi.org/10.7326/0003-4819-151-2-200907210-00009</mixed-citation></ref><ref id="hanspub.35103-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Wiseman, M. (2008) The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Pre-vention of Cancer: A Global Perspective. Proceedings of the Nutra Society, 67, 253-256. &lt;br&gt;https://doi.org/10.1017/S002966510800712X</mixed-citation></ref><ref id="hanspub.35103-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Jakszyn, P. and Gonzalez, C.A. (2006) Nitrosamine and Related Food Intake and Gastric and Esophageal Cancer Risk: A Systematic Review of the Epidemiological Evidence. World Journal of Gastroenterology, 12, 4296-4303. 
&lt;br&gt;https://doi.org/10.3748/wjg.v12.i27.4296</mixed-citation></ref><ref id="hanspub.35103-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.P., Sung, I.K., Kim, J.H., et al. (2015) The Effect of Emo-tional Stress and Depression on the Prevalence of Digestive Diseases. Journal of Neurogastroenterology and Motility, 21, 273-282. &lt;br&gt;https://doi.org/10.5056/jnm14116</mixed-citation></ref></ref-list></back></article>